Latest health news from http://reuters.us.feedsportal.com/c/35217/f/654207/s/49acb549/sc/14/l/0L0Sreuters0N0Carticle0C20A150C0A90C0A80Cus0Eglaxosmithkline0Etheravance0Ebreo0EidUSKCN0AR82GN20A150A90A80DfeedType0FRSS0GfeedName0FhealthNews/story01.htm
Tuesday, September 8, 2015
Glaxo, Theravance Breo lung drug fails to extend life in huge study
(Reuters) - GlaxoSmithKline Plc and its partner Theravance Inc on Tuesday said their inhaled medicine Breo failed in a huge, high-stakes clinical trial to prolong life of patients with chronic pulmonary respiratory disease.
Latest health news from http://reuters.us.feedsportal.com/c/35217/f/654207/s/49acb549/sc/14/l/0L0Sreuters0N0Carticle0C20A150C0A90C0A80Cus0Eglaxosmithkline0Etheravance0Ebreo0EidUSKCN0AR82GN20A150A90A80DfeedType0FRSS0GfeedName0FhealthNews/story01.htm
Latest health news from http://reuters.us.feedsportal.com/c/35217/f/654207/s/49acb549/sc/14/l/0L0Sreuters0N0Carticle0C20A150C0A90C0A80Cus0Eglaxosmithkline0Etheravance0Ebreo0EidUSKCN0AR82GN20A150A90A80DfeedType0FRSS0GfeedName0FhealthNews/story01.htm
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment